The Oxford-AstraZeneca vaccine-related death of a 54-year-old South Shore woman continues to elicit reaction in Quebec. While the woman's fatal blood clot was a rare complication, members of the National Assembly worry this may have a negative impact on the province's vaccination campaign. Global’s Raquel Fletcher reports.